Production (Stage)
ICU Medical, Inc.
ICUI
$128.99
-$1.74-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.99% | 6.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.99% | 6.90% | |||
| Cost of Revenue | -1.98% | 4.75% | |||
| Gross Profit | -7.55% | 10.94% | |||
| SG&A Expenses | -1.02% | -2.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.48% | 2.77% | |||
| Operating Income | -35.76% | 118.09% | |||
| Income Before Tax | -232.72% | 145.83% | |||
| Income Tax Expenses | -85.74% | 112.85% | |||
| Earnings from Continuing Operations | 35.05% | 27.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.05% | 27.76% | |||
| EBIT | -35.76% | 118.09% | |||
| EBITDA | -20.21% | 28.98% | |||
| EPS Basic | 35.17% | 27.92% | |||
| Normalized Basic EPS | -60.51% | 403.87% | |||
| EPS Diluted | 35.73% | 27.31% | |||
| Normalized Diluted EPS | -60.51% | 403.87% | |||
| Average Basic Shares Outstanding | 0.19% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||